-
Allergan Now Trades Cheaper Than Its Standalone Value
Tuesday, April 5, 2016 - 11:07am | 756Read More...Shibani Malhotra of Nomura thinks Allergan plc Ordinary Shares (NYSE: AGN) is compelling, despite treasury notice that threatens the company's $160 billion merger with Pfizer Inc. (NYSE: PFE). Allergan shares fell as much as 20 percent amid fears that the U.S. Treasury Department and the...
-
Nomura Analysts Calls Disney COO Departure 'Surprising And Unexpected'
Tuesday, April 5, 2016 - 9:52am | 491Read More...Walt Disney Co (NYSE: DIS)'s departure announcement of Tom Staggs, the company's Chief Operating Officer (and previously considered "heir apparent" to the CEO), is "certainly surprising and unexpected," according to Nomura. Staggs will be stepping down from his position as of May 6, 2016, according...
-
Macau Revenue Misses Expectations, Casino Stocks Mostly Lower
Friday, April 1, 2016 - 1:38pm | 310Read More...Casino stocks were trading mostly lower on Friday after Bloomberg reported gaming revenue generated in Macau fell more than expected last month. Bloomberg, citing data from Macau's Gaming Inspection and Coordination Bureau, reported that total gross gaming revenue in the region fell 16.3...
-
Should PepsiCo Go 'Asset-Light' Like Coca-Cola?
Thursday, March 31, 2016 - 10:52am | 248Read More...Much has been written about The Coca-Cola Co (NYSE: KO) creating a more asset-light model by divesting most of its owned bottling assets. Nomura’s Ian Shackleton pointed out that a higher ROIC could result in more returns to shareholders. Similar Strategy By PepsiCo If PepsiCo, Inc. (...
-
Endo's Selloff An 'Overreaction,' Nomura Says
Monday, March 21, 2016 - 10:44am | 253Read More...Nomura’s Shibani Malhotra maintained a Buy rating on Endo International plc - Ordinary Shares (NASDAQ: ENDP), with a price target of $80. Overreaction To Minor Update Malhotra believes the selloff in the stock, following a “minor update” by the company, was an overreaction...
-
Nomura Starts MedTech Group: STJ, BSX, ZBH, EW, MDT, SYK At Buy, BCR At Neutral
Thursday, March 17, 2016 - 10:04am | 401Read More...Nomura’s Ed Ridley initiated coverage of the Global MedTech sector with a Neutral stance, while mentioning that the sector offers relatively visible structural growth at a time when global growth remained subdued and the European economy continued to be weak. Visible Structural Growth...
-
Nomura Downgrades Vale, BHP Billiton From Buy To Neutral
Thursday, March 17, 2016 - 9:48am | 450Read More...Nomura’s Alexander M. Burnes said that Global Metals & Mining represented a “tale of paradigms & anarchy.” He added that the view on the sector was cautious, and recommended quality stocks. An earlier report had suggested that the incentive pricing theory [IPT] model...
-
Nomura Downgrades Valeant, Says It's Been 'Humbled'
Wednesday, March 16, 2016 - 11:47am | 166Read More...Nomura’s Shibani Malhotra downgraded Valeant Pharmaceuticals Intl Inc (NYSE: VRX) from Buy to Neutral, while slashing the price target from $175 to $60. She commented, “We have lost conviction in Valeant.” The company has announced a larger reduction in its 2016 than was...
-
Nomura Hikes Wendy's Sales Outlook After 'Favorable' Burger Channel Checks
Wednesday, March 9, 2016 - 12:10pm | 240Read More...Nomura analyst Mark Kalinowski raised his Q1 same-store sales forecast for Wendys Co (NASDAQ: WEN) after "favorable" channel checks, sending shares up 1 percent. The analyst, who has a Buy rating on Wendy's, increased his Q1 same-store sales projection for the company-owned...
-
Nomura Meets With Dow Chemical, Now More Positive On DuPont Synergies
Tuesday, March 8, 2016 - 11:34am | 358Read More...The forthcoming merger between Dow Chemical Co (NYSE: DOW) and E L Du Pont De Nemours And Co (NYSE: DD) has ushered in much talk regarding the implications of such a significantly massive conglomerate. Additionally, rumors circulated earlier this week suggested that BASF SE (ADR) (OTC: BASFY),...
-
Nomura On Industrials: Upgrades Ingersoll-Rand To Buy
Monday, March 7, 2016 - 11:51am | 304Read More...Nomura’s Jonathan Wright upgraded the rating on Ingersoll-Rand PLC (NYSE: IR) to Buy, while raising the price target from $56 to $68. CRI As A Measure Of Business Quality Wright explained that although cash return on investment (CRI) had been identified as the “best measure of a...
-
'Controversial' Micron Has 32% Downside, Nomura Warns After Asia Trip
Monday, March 7, 2016 - 10:12am | 283Read More...Nomura’s Romit Shah downgraded the rating for Micron Technology, Inc. (NASDAQ: MU) from Neutral to Reduce, while reducing the price target from $12 to $8. Micron’s shares have declined 60 percent, versus a 3 percent decline in the S&P, over the last one year. Analyst Romit Shah...
-
Nomura Expects Apple's Rising Subscriber Base To 'Ultimately Restore Volume Growth'
Friday, March 4, 2016 - 9:35am | 223Read More...Nomura's Jeffrey Kvaal maintained a Buy rating on Apple Inc. (NASDAQ: AAPL), with a price target of $135. Following Nomura's Asia Tour, Kvaal said, "We found both the long-term and near-term implications for Apple to be positive overall." Despite lower-than-expected iPhone...
-
China's Manufacturing Sector Just Hit A 51-Month Low
Tuesday, March 1, 2016 - 11:21am | 317Read More...The official China PMI eased from 49.4 in January to 49.0 in February – its lowest level in 51 months. The PMI number for February fell short of consensus expectations of 49.4. According to Nomura analyst Yang Zhao, the PMI is likely headed lower from here, despite the possibility of more...
-
Berkshire Hathaway Book Value Keeps Growing; Nomura Still Buying
Monday, February 29, 2016 - 4:27pm | 214Read More...Nomura said Berkshire Hathaway Inc. (NYSE: BRK-A)'s book value moves upwards despite headwinds from weak oil prices. Analyst Clifford Gallant cut his target price to $235,000 from $239,000. For the fourth quarter, Berkshire Hathaway's profit rose to $5.48 billion, or $3,333 per Class A share, from...
